102 related articles for article (PubMed ID: 28983617)
21. [Effects of Wnt3a on proliferation, activation and the expression of TGFb/Smad in rat hepatic stellate cells].
Wang YP; He Q; Wu F; Zhu LL; Liu W; Zhang YN; He YW
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):111-5. PubMed ID: 23663882
[TBL] [Abstract][Full Text] [Related]
22. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
23. Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling.
Seyhan H; Hamzavi J; Wiercinska E; Gressner AM; Mertens PR; Kopp J; Horch RE; Breitkopf K; Dooley S
J Cell Mol Med; 2006; 10(4):922-32. PubMed ID: 17125595
[TBL] [Abstract][Full Text] [Related]
24. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
[TBL] [Abstract][Full Text] [Related]
25. Effects of tacrolimus on the TGF‑β1/SMAD signaling pathway in paraquat‑exposed rat alveolar type II epithelial cells.
Ren Y; Jian X; Zhang Z; Ning Q; Kan B; Kong L
Mol Med Rep; 2020 Nov; 22(5):3687-3694. PubMed ID: 33000210
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of syndecan‑1 expression induces activation of hepatic stellate cells via the TGF‑β1/Smad3 signaling pathway.
Deng M; Xu L; Xie X; Sheng X; Zou Z; Yao M
Mol Med Rep; 2019 Jul; 20(1):368-374. PubMed ID: 31115505
[TBL] [Abstract][Full Text] [Related]
27. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
28. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
Zhu J; Zhang Z; Zhang Y; Li W; Zheng W; Yu J; Wang B; Chen L; Zhuo Q; Chen L; Zhang J; Liu J
Biochem Biophys Res Commun; 2018 Jan; 496(1):176-183. PubMed ID: 29307832
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
Weng H; Mertens PR; Gressner AM; Dooley S
J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
[TBL] [Abstract][Full Text] [Related]
31. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of action of acetaldehyde in the up-regulation of the human α2(I) collagen gene in hepatic stellate cells: key roles of Ski, SMAD3, SMAD4, and SMAD7.
Reyes-Gordillo K; Shah R; Arellanes-Robledo J; Hernández-Nazara Z; Rincón-Sánchez AR; Inagaki Y; Rojkind M; Lakshman MR
Am J Pathol; 2014 May; 184(5):1458-67. PubMed ID: 24641900
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑20b‑5p promotes ventricular remodeling by targeting the TGF‑β/Smad signaling pathway in a rat model of ischemia‑reperfusion injury.
Liang ZG; Yao H; Xie RS; Gong CL; Tian Y
Int J Mol Med; 2018 Aug; 42(2):975-987. PubMed ID: 29786750
[TBL] [Abstract][Full Text] [Related]
34. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
35. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
36. SMAD3 expression and regulation of fibroplasia in vocal fold injury.
Hiwatashi N; Benedict PA; Dion GR; Bing R; Kraja I; Amin MR; Branski RC
Laryngoscope; 2017 Sep; 127(9):E308-E316. PubMed ID: 28543554
[TBL] [Abstract][Full Text] [Related]
37. The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.
Tjomsland V; Sandnes D; Pomianowska E; Cizmovic ST; Aasrum M; Brusevold IJ; Christoffersen T; Gladhaug IP
J Exp Clin Cancer Res; 2016 Jul; 35(1):122. PubMed ID: 27473228
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
39. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
40. Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.
Kim S; Han J; Lee SK; Koo M; Cho DH; Bae SY; Choi MY; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Cancer Lett; 2012 Jan; 314(2):147-54. PubMed ID: 22033246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
